Literature DB >> 9829355

Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer.

A E Henriksson1, A C Edman, I Nilsson, D Bergqvist, T Wadström.   

Abstract

BACKGROUND: The influence of ulcer risk factors is well known in chronic peptic ulcer disease. In this study the risk factors were investigated in patients with peptic ulcer complicated by an acute bleeding episode.
METHOD: In 106 consecutive patients with acute bleeding peptic ulcer, age, previous history of ulcer disease, presence of dyspeptic symptoms, smoking habits, consumption of nonsteroidal anti-inflammatory drugs (NSAIDs), and haemoglobin concentration at admission were recorded. Helicobacter pylori infection was detected by means of two serologic tests in samples obtained at admission for the acute bleeding episode.
RESULTS: Three-quarters of both gastric ulcer and duodenal ulcer patients were shown to have H. pylori antibodies. NSAID use and smoking habits were similar in patients with and without H. pylori antibodies.
CONCLUSIONS: The results indicate that H. pylori infection, NSAID use, and smoking habits act as largely independent risk factors in patients with acute bleeding peptic ulcer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9829355     DOI: 10.1080/003655298750026705

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

1.  Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.

Authors:  Hibiki Ootani; Ryuichi Iwakiri; Ryo Shimoda; Shin Nakahara; Sadahiro Amemori; Takehiro Fujise; Atsushi Kikkawa; Seiji Tsunada; Hiroyuki Sakata; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

2.  Does physical activity reduce the risk of developing peptic ulcers?

Authors:  Y Cheng; C A Macera; D R Davis; S N Blair
Journal:  Br J Sports Med       Date:  2000-04       Impact factor: 13.800

3.  Physical activity and peptic ulcers. Does physical activity reduce the risk of developing peptic ulcers?

Authors:  Y Cheng; C A Macera; D R Davis; S N Blair
Journal:  West J Med       Date:  2000-08

Review 4.  Gastroenterostoma after Billroth antrectomy as a premalignant condition.

Authors:  Robert Sitarz; Ryszard Maciejewski; Wojciech P Polkowski; G Johan A Offerhaus
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

5.  A new subtype of 3' region of cagA gene in Helicobacter pylori strains isolated from Zhejiang Province in China.

Authors:  Ran Tao; Ping-Chu Fang; Hai-Yan Liu; Yun-Shui Jiang; Jing Chen
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

6.  Genotypes of Helicobacter pylori in patients with peptic ulcer bleeding.

Authors:  Chin-Lin Perng; Hwai-Jeng Lin; Wen-Ching Lo; Guan-Ying Tseng; I-Chen Sun; Yueh-Hsing Ou
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

7.  Time trends in incidence of peptic ulcer bleeding and associated risk factors in Norway 1985-2008.

Authors:  Kåre E Bakkevold
Journal:  Clin Exp Gastroenterol       Date:  2010-06-29

8.  Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.

Authors:  Michael Hermansson; Anders Ekedahl; Jonas Ranstam; Thomas Zilling
Journal:  BMC Gastroenterol       Date:  2009-04-20       Impact factor: 3.067

9.  Seasonal variation of peptic ulcer disease, peptic ulcer bleeding, and acute pancreatitis: A nationwide population-based study using a common data model.

Authors:  Jin Young Yoon; Jae Myung Cha; Ha Il Kim; Min Seob Kwak
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

Review 10.  Diagnosis, treatment, and outcome in patients with bleeding peptic ulcers and Helicobacter pylori infections.

Authors:  Ting-Chun Huang; Chia-Long Lee
Journal:  Biomed Res Int       Date:  2014-06-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.